TrialBreast cancer research and treatment2010

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group trial E3198.

Antonio C Wolff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.